SRES-293-117
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S4796; text: CR S4785-4786)
Sponsored by Sheldon Whitehouse (D-RI)
What it does
This Senate resolution designates June 26, 2021, as the "International Day against Drug Abuse and Illicit Trafficking." It expresses the Senate's support for efforts to address substance use and prevent drug trafficking and production. The resolution carries no binding legal force, creates no new law, and allocates no funding.
Who benefits
Advocacy organizations and public health groups working on substance use and drug trafficking issues may gain symbolic visibility and political validation from the Senate's formal expression of support. International partners and United Nations bodies that coordinate the annual observance — which was established by the UN General Assembly in 1987 — may view the resolution as a reaffirmation of U.S. alignment with global anti-drug efforts.
Who is hurt
No specific group is directly or materially harmed by this resolution. Because it is purely symbolic and non-binding, it does not impose costs, restrictions, or obligations on any individual, organization, or government entity.
Supporters argue
Supporters contend that formal congressional recognition of the International Day against Drug Abuse and Illicit Trafficking sends a meaningful signal of U.S. commitment to global cooperation on drug policy. They argue that symbolic resolutions reinforce diplomatic relationships with international partners, elevate public awareness of the harms caused by substance use and trafficking, and provide a platform for communities, educators, and health organizations to draw attention to prevention and treatment efforts. Supporters also note that the resolution passed by unanimous consent, reflecting broad bipartisan agreement that addressing drug abuse and trafficking is a shared national priority worthy of acknowledgment.
Opponents argue
Opponents contend that symbolic resolutions like this one consume limited Senate floor time and legislative resources without producing any concrete policy outcome, funding, or enforceable commitment. They argue that expressing support for addressing drug abuse and trafficking through a non-binding designation does nothing to change the laws, programs, or international agreements that actually govern these issues. Critics may further suggest that the Senate's attention would be better directed toward substantive legislation — such as changes to drug scheduling, interdiction funding, or treatment program authorization — that would produce measurable results rather than a ceremonial acknowledgment.